$MAC

MACERICH CO (MAC): Results of Operations and Financial Condition

MACERICH CO (MAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2-exhibit991.htm EX-99.1 2026 Q2- Exhibit 99.1 Exhibit 99.1 Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 2026 The Macerich Company Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 20

Original reporting
Published Aug 4, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MAC
Neutral
medium confidence
Mentioned
$MAC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MACNeutralMed
01

Why it matters

Traders can update models for adjusted FFO, occupancy, leasing pipeline conversion, and balance-sheet changes from new debt and equity issuance tied to acquisitions and leasing capital investments.

02

Market read

The filing is a combined operating and capital-structure update, with specific terms for mortgage financing and large equity offerings that can drive dilution and leverage expectations.

03

What to watch

Investors may focus on the cost of capital (mortgage rate, equity issuance pricing) and the timing of conversion from signed-not-open leases into revenue, which is not fully quantified here.

Relevance 7/10Novelty 7/10Timing: filed after market close, for next-session positioning

Background

This is Macerich’s SEC 8-K filing for Q2 2026 results, including an earnings supplemental package and detailed capital activity.

Company-level read

Ticker impact

$MACNeutralMedium confidence
Context

Macerich reported Q2 2026 results and disclosed financing and equity issuance, including a $448.2M upsized stock offering and an Annapolis Mall acquisition.

Expected impact

Near-term trading likely hinges on whether investors view the new equity issuance and acquisition funding as value-accretive versus dilutive, with occupancy and NOI growth providing offsetting support.

Evidence & confidence

The article provides multiple concrete datapoints (net loss, adjusted FFO, occupancy, signed pipeline, and specific capital-raising terms) but does not include forward guidance or a full valuation framework, limiting precision on direction.

Market effects

Reinforces the mall REIT playbook of using equity and secured debt to fund repositioning and leasing pipelines, potentially informing read-across for retail REIT capital markets.

Highlights demand and leasing momentum in Macerich’s core geographies (California, Pacific Northwest, Phoenix/Scottsdale, and Metro New York to Washington, D.C.).

Limited direct global relevance; primarily US retail real estate and capital markets.

Counterpoint

The improved NOI and occupancy could be partially offset by dilution from large equity offerings and the drag from acquisition integration, so the net effect may be less bullish than it appears.

Key entities

  • The Macerich Company

    Reported Q2 2026 operating metrics (net loss, adjusted FFO, NOI growth, occupancy, tenant sales) and disclosed financing and equity issuance plus the Annapolis Mall acquisition.

  • Annapolis Mall

    Class A regional mall acquired for $260M plus $12M for an adjacent Sears parcel, with onboarding and retailer openings referenced.

Related articles

$MACMedAI 8/10

Macerich Company: Macerich Announces Pricing of Upsized Offering of $675 Million Exchangeable Senior Notes due 2031

Macerich (NYSE: MAC) priced an upsized $675 million offering of 2.25% exchangeable senior notes due 2031, up from $600 million. The notes settle Aug. 11, 2026, pay 2.25% semiannually, mature Aug. 15, 2031, and are exchangeable into MAC shares at an initial rate of 35.4761 shares per $1,000 principal. Net proceeds are about $659.1 million.

$MACMed

The Macerich Company Q2 2026 Earnings Call Summary

Macerich reported progress on its Path Forward 3.0 plan, with leasing completion at 88% versus a midyear 85% target. Management reiterated 2026 go-forward portfolio NOI growth of at least 3%, accelerating to 3.5%+ in 2H, and expects >8% NOI growth in 2027-28 as a $140 million SNO pipeline contributes rent. Net debt/adj. EBITDA improved to 7.3x. The company plans $372 million of unsettled forward equity for acquisitions and noted a $76 million loan default at 29th Street.

$MACMed

Mall Giant Macerich Narrows Losses in Q2 Amid Stronger Leasing

Macerich (a mall REIT) reported Q2 leased occupancy of 94% (up from 92% a year earlier) after signing about 1.3 million sq ft of new and renewal leases. Lease revenue was $233.4M and total revenue $249.7M. Adjusted FFO was $100.4M. Net loss narrowed to $27.1M from nearly $41M, helped by asset sales. Go-forward NOI rose 3.8% and the company cited $1.2B liquidity.

$MACMed

Macerich (NYSE:MAC) Stock Rating Upgraded by JPMorgan Chase & Co.

JPMorgan upgraded Macerich (NYSE:MAC) from “underweight” to “neutral” and set a $25.00 price target, implying 5.34% upside from the prior close, according to MarketBeat. Other firms cited include Deutsche Bank (to “buy,” $27 target) and Goldman Sachs (to “sell,” $19 target). Macerich reported $0.34 EPS and $241.54M revenue for Q ended May 6.

$MACMed

Macerich Announces Commencement of Public Offering of Common Stock

Macerich (NYSE: MAC) said it has started an underwritten public offering of 14,000,000 shares of common stock, with Goldman Sachs & Co. LLC as lead bookrunner. The underwriters have a 30-day option to buy up to 2,100,000 additional shares. Macerich expects to enter forward sale agreements with financial institutions; it will not receive initial proceeds, with net proceeds expected upon future settlement to fund acquisitions and general corporate purposes.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.